Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
MEDINA trial
ISRCTN61411165Phase 3Completed
- Sponsor
- DSC Services
- Start
- Nov 2008
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, open-label trial of losartan, valsartan, ramipril, perindopril, hydrochlorothiazide and 1 more in type 2 diabetes mellitus (T2DM), essential hypertension and cardiometabolic risk (CMR) (2 arms), sponsored by DSC Services. Primary endpoints: Waist measurement, Metabolic and renal blood markers and 4 more. Started Nov 2008; status: completed.
02
Drugs
losartanvalsartanramiprilperindoprilhydrochlorothiazide
03
Conditions
type 2 diabetes mellitus (T2DM)essential hypertensioncardiometabolic risk (CMR)
Beyond the preview
Go deeper on ISRCTN61411165.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ISRCTN61411165.